Tourette syndrome in children and adolescents: special considerations
- PMID: 19913657
- DOI: 10.1016/j.jpsychores.2009.08.003
Tourette syndrome in children and adolescents: special considerations
Abstract
Tourette syndrome (TS) affects people of all ages, with onset in early childhood and continuing through the different stages of the life cycle into adolescence and adults. This review focuses on barriers to diagnosis and challenges in the management of young patients with TS. Barriers to identification occur at multiple levels, including detection in the community setting (including schools), parents' help-seeking behavior, and cultural influences on such behavior, as well as diagnosis by the medical provider. Challenges to management include unfamiliarity of primary care providers, inconsistencies in the diagnosis and management plan, and failure to recognize comorbid conditions, as well as inadequate knowledge and lack of resources to effectively deal with comorbidities. In addition to the complexities posed by pharmacological interactions, there are unique psychosocial challenges experienced by young people with TS and their families. Effective communication and collaboration between families, health care providers, and school personnel, as well as supportive communities, are essential components of comprehensive management.
Similar articles
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Family pediatrics: report of the Task Force on the Family.Pediatrics. 2003 Jun;111(6 Pt 2):1541-71. Pediatrics. 2003. PMID: 12777595
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.Semin Pediatr Neurol. 2005 Dec;12(4):217-21. doi: 10.1016/j.spen.2005.12.003. Semin Pediatr Neurol. 2005. PMID: 16780292 Review.
-
Clinical phenomenology and phenotype variability in Tourette syndrome.J Psychosom Res. 2009 Dec;67(6):491-6. doi: 10.1016/j.jpsychores.2009.07.011. J Psychosom Res. 2009. PMID: 19913653 Review.
Cited by
-
How does Tourette syndrome impact adolescents' daily living? A text mining study.Eur Child Adolesc Psychiatry. 2023 Dec;32(12):2623-2635. doi: 10.1007/s00787-022-02116-1. Epub 2022 Dec 2. Eur Child Adolesc Psychiatry. 2023. PMID: 36460852 Free PMC article.
-
Social communication deficits and restricted repetitive behavior symptoms in Tourette syndrome.Neuropsychiatr Dis Treat. 2019 Jul 26;15:2151-2160. doi: 10.2147/NDT.S210227. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31440054 Free PMC article.
-
Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism.Transl Psychiatry. 2012 Sep 4;2(9):e158. doi: 10.1038/tp.2012.75. Transl Psychiatry. 2012. PMID: 22948383 Free PMC article. Review.
-
The Impact of Tic Severity, Comorbidity and Peer Attachment on Quality of Life Outcomes and Functioning in Tourette's Syndrome: Parental Perspectives.Child Psychiatry Hum Dev. 2016 Aug;47(4):563-73. doi: 10.1007/s10578-015-0590-7. Child Psychiatry Hum Dev. 2016. PMID: 26440978
-
Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics.Neuropsychiatr Dis Treat. 2015 Jun 11;11:1431-6. doi: 10.2147/NDT.S72284. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26089672 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical